Chicago Tribune (December 21)
“Even as the first vaccine shots begin to roll out to health care workers, doctors and nurses say they are struggling to make it through the pandemic’s darkest surge yet, in an atmosphere some describe as bordering on exhaustion.” The staff shortage is now “nationwide, to the point that Illinois’ staffing woes seem merely average by comparison. In California, Wisconsin and Virginia, around 30% of hospitals are reporting critical staffing shortages. It’s closer to 40% in Arizona and Missouri.”
Tags: California, Darkest surge, Doctors, Exhaustion, Health care workers, Hospitals Arizona, Illinois, Nurses, Pandemic, Staff shortage, Struggling, Vaccine
San Francisco Chronicle (December 15)
“Even as the first precious caches of coronavirus vaccine arrived in counties across California Monday, the pandemic showed no signs of abating, with hospitals straining under an influx of COVID-19 patients and deaths climbing across the state and region.”
Tags: Abating, California, Coronavirus, COVID-19, Hospitals, Influx, Pandemic, Patients, Precious, Straining, Vaccine
Financial Times (November 16)
“The US economy is facing an accelerating surge in coronavirus cases and harsh new restrictions on business activity without the cushion of meaningful fiscal support, raising fears of a blow to the recovery.” The market has rallied on vaccine advances, but “the deteriorating health situation across the country presents an imminent threat to the US economy as the winter months approach.”
Tags: Accelerating, Advances, Coronavirus, Deteriorating, Economy, Fears, Fiscal, Rallied, Recovery, Restrictions, Support, Surge, US, Vaccine
The Economist (November 14)
“Suddenly, hope. The promise of the new covid-19 vaccine is immense, but don’t underestimate the challenge of getting people vaccinated.”
Tags: Challenge, COVID-19, Hope, Promise, Sudden, Underestimate, Vaccinated, Vaccine
Financial Times (November 10)
“After the long night of Covid-19, a faint glow is visible on the horizon.” Pfizer’s 90% efficacy is more than we could dream for in a vacine, but the “euphoria should be tempered; any return to normality will take time…. Science has made a breakthrough. But don’t throw away your face covering just yet.”
Tags: 90%, Breakthrough, COVID-19, Efficacy, Euphoria, Normality, Pfizer, Science, Tempered, Time, Vaccine
Bloomberg (September 24)
“As the likelihood of additional federal stimulus fades, U.S. stock investors are returning their focus to the coronavirus pandemic and not liking what they see.” Consumers are again cutting back and “the prospects for a vaccine in the next few months have also waned just as the latest data shows an uptick in cases.” Moves by the Federal Reserve and “$3 trillion of federal stimulus helped fuel a torrid five-month rally that began in March,” but “their limitations have become clear.”
Tags: Consumers, Coronavirus, Cutting back, Fed, Limitations, Pandemic, Rally, Stimulus, Stock investors, U.S., Uptick, Vaccine
San Francisco Chronicle (July 13)
“A vaccine may not be enough to end the coronavirus pandemic and restore society to some semblance of normalcy.” Effective treatments may prove just as important. “Researchers across the globe are racing to find drugs that can keep more people alive and out of the hospital—and any one of those treatments may ultimately work just as well as a vaccine.”
Tags: Alive, Coronavirus, Drugs, Effective, Hospital, Normalcy, Pandemic, Researchers, Restore, Society, Treatments, Vaccine
Financial Times (June 20)
“A vaccine that allows people to live, work, travel, learn and socialize together safely again is the best long term exit strategy from lockdown.” With 183 vaccines under study, “the chances that one of those will come good seem hopeful but success is not guaranteed. There is still no vaccine against HIV, a plague that has now been with us for 40 years.”
Tags: Exit strategy, Guaranteed, HIV, Lockdown, Safely, Success, Travel, Vaccine, Work
Bloomberg (May 7)
“It’s easy to lose sight of the scariest scenario of them all: the one where there’s no magic bullet.” Without a vaccine breakthrough, “herd immunity would come, if at all, only after millions of deaths around the world.” While this scenario is unpalatable, “it isn’t defeatism to ask what the world will look like if we lose the war we’re fighting. It’s realism.”
Tags: Deaths, Defeatism, Herd immunity, Magic bullet, Realism, Scenario, Vaccine
New York Times (April 28)
“Delaying the Tokyo Games by a year already poses enormous economic, political and logistical challenges, including whether Japan can hope to recoup its $10 billion investment.” Without a vaccine, however, a 2021 “timeline may be optimistic.”
Tags: Challenges, Delay, Economic, Investment, Japan, Logistical, Optimistic, Political, Recoup, Timeline, Tokyo, Vaccine
